UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Benefits from Treatment and Control of Patients with Resistant Hypertension

International Journal of Hypertension, 2011-01, Vol.2011 (2011), p.14-21

2011

Volltextzugriff (PDF)

Pathophysiology of Resistant Hypertension: The Role of Sympathetic Nervous System

International Journal of Hypertension, 2011-01, Vol.2011 (2011), p.55-61

2011

Volltextzugriff (PDF)

Plasma renin and the antihypertensive effect of the orally active renin inhibitor aliskiren in clinical hypertension

International journal of clinical practice (Esher), 2007-09, Vol.61 (9), p.1461-1468

2007

Volltextzugriff (PDF)

Adding nebivolol to ongoing antihypertensive therapy improves blood pressure and response rates in patients with uncontrolled stage I-II hypertension

Journal of human hypertension, 2010-01, Vol.24 (1), p.64-73

2010

Volltextzugriff (PDF)

Renal Sympathetic Denervation for the Treatment of Difficult-to-Control or Resistant Hypertension

International Journal of Hypertension, 2011-01, Vol.2011 (2011), p.212-219

2011

Volltextzugriff (PDF)

Efficacy, safety and tolerability of aliskiren, a direct renin inhibitor, in women with hypertension: a pooled analysis of eight studies

Journal of human hypertension, 2010-11, Vol.24 (11), p.721-729

2010

Volltextzugriff (PDF)

Current concepts: renin inhibition in the treatment of hypertension

Current opinion in pharmacology, 2008-04, Vol.8 (2), p.120-126

2008

Volltextzugriff (PDF)

Additivity of Nebivolol/Valsartan Single-Pill Combination Versus Other Single-Pill Combinations for Hypertension

Journal of the American Society of Hypertension, 2016-07, Vol.10, p.e5-e6

2016

Volltextzugriff (PDF)

Effect of nesiritide on renal function in patients admitted for decompensated heart failure

QJM : An International Journal of Medicine, 2007-11, Vol.100 (11), p.699-706

2007

Volltextzugriff (PDF)

AT1-receptor blockers: differences that matter

Journal of human hypertension, 2002-08, Vol.16 (S3), p.S9-S16

Gradman, A H

2002

Volltextzugriff (PDF)

Ambulatory Blood Pressure Monitoring in Resistant Hypertension

International Journal of Hypertension, 2011-01, Vol.2011 (2011), p.235-238

2011

Volltextzugriff (PDF)

Adding nebivolol to ongoing antihypertensive therapy improves blood pressure and response rates in patients with uncontrolled stage I-II hypertension

Journal of human hypertension, 2010-06, Vol.24 (6), p.430-430

2010

Volltextzugriff (PDF)

Long-Term Use of Aldosterone-Receptor Antagonists in Uncontrolled Hypertension: A Retrospective Analysis

International Journal of Hypertension, 2011, Vol.2011 (2011), p.177-188

2011

Volltextzugriff (PDF)

AT(1)-receptor blockers: differences that matter

Journal of human hypertension, 2002-08, Vol.16 Suppl 3, p.S9

Gradman, A H

2002

Volltextzugriff (PDF)

A Randomized, Placebo-Controlled, Double-Blind, Parallel Study of Various Doses of Losartan Potassium Compared With Enalapril Maleate in Patients With Essential Hypertension

Hypertension (Dallas, Tex. 1979), 1995-06, Vol.25 (6), p.1345-1350

1995

Volltextzugriff (PDF)

E079 Comparison of the impact of missed doses of tasosartan and losartan on control of ambulatory blood pressure in essential hypertension

American journal of hypertension, 1998-04, Vol.11 (S3), p.115A-115A

Gradman, A.

1998

Volltextzugriff (PDF)

Long-term benefits of angiotensin II blockade: is the consensus changing?

The American journal of cardiology, 1999-11, Vol.84 (10), p.16-21

Gradman, Alan H

1999

Volltextzugriff (PDF)

Effects of low-dose oral enoximone administration on mortality, morbidity, and exercise capacity in patients with advanced heart failure: the randomized, double-blind, placebo-controlled, parallel group ESSENTIAL trials

European heart journal, 2009-12, Vol.30 (24), p.3015-3026

2009

Volltextzugriff (PDF)

From Left Ventricular Hypertrophy to Congestive Heart Failure: Management of Hypertensive Heart Disease

Progress in cardiovascular diseases, 2006-03, Vol.48 (5), p.326-341

2006

Volltextzugriff (PDF)

Combined Enalapril and Felodipine Extended Release (ER) for Systemic Hypertension

The American journal of cardiology, 1997-02, Vol.79 (4), p.431-435

1997

Volltextzugriff (PDF)

Aliskiren, a novel orally effective renin inhibitor, provides dose-dependent antihypertensive efficacy and placebo-like tolerability in hypertensive patients

Circulation (New York, N.Y.), 2005-03, Vol.111 (8), p.1012-1018

2005

Volltextzugriff (PDF)

Supraventricular tachycardia in patients with right hemisphere strokes

Stroke (1970), 1992-03, Vol.23 (3), p.362-366

1992

Volltextzugriff (PDF)

Underutilization and clinical benefits of angiotensin-converting enzyme inhibitors in patients with asymptomatic left ventricular dysfunction

The American journal of cardiology, 2000-09, Vol.86 (6), p.644-648

2000

Volltextzugriff (PDF)

Aliskiren, a novel orally effective renin inhibitor, provides antihypertensive efficacy and placebo-like tolerability similar to an at1-receptor blocker in hypertensive patients

American journal of hypertension, 2004-05, Vol.17 (5), p.S108

GRADMAN, A

2004

Volltextzugriff (PDF)

Manual or semi-automated edge detection of the maximal far wall common carotid intima-media thickness: a direct comparison

Journal of internal medicine, 2012-03, Vol.271 (3), p.247-256

2012

Volltextzugriff (PDF)

1 – 25 von 310

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(283)
Mit Volltextzugriff
(251)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(148)
Science & Technology
(141)
Life Sciences & Biomedicine
(139)
Cardiovascular System & Cardiology
(86)
Male
(83)
Female
(74)
Biological And Medical Sciences
(64)
Medical Sciences
(62)
Middle Aged
(60)
Hypertension
(59)
Hypertension - Drug Therapy
(50)
Peripheral Vascular Disease
(49)
Cardiac & Cardiovascular Systems
(47)
Aged
(45)
Adult
(34)
Pharmacology. Drug Treatments
(34)
Treatment Outcome
(31)
Antihypertensive Agents - Therapeutic Use
(30)
Double-Blind Method
(30)
Cardiovascular System
(29)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Benefits from Treatment and Control of Patients with Resistant Hypertension

Pathophysiology of Resistant Hypertension: The Role of Sympathetic Nervous System

Plasma renin and the antihypertensive effect of the orally active renin inhibitor aliskiren in clinical hypertension

Adding nebivolol to ongoing antihypertensive therapy improves blood pressure and response rates in patients with uncontrolled stage I-II hypertension

Renal Sympathetic Denervation for the Treatment of Difficult-to-Control or Resistant Hypertension

Efficacy, safety and tolerability of aliskiren, a direct renin inhibitor, in women with hypertension: a pooled analysis of eight studies

Current concepts: renin inhibition in the treatment of hypertension

Additivity of Nebivolol/Valsartan Single-Pill Combination Versus Other Single-Pill Combinations for Hypertension

Effect of nesiritide on renal function in patients admitted for decompensated heart failure

AT1-receptor blockers: differences that matter

Ambulatory Blood Pressure Monitoring in Resistant Hypertension

Adding nebivolol to ongoing antihypertensive therapy improves blood pressure and response rates in patients with uncontrolled stage I-II hypertension

Long-Term Use of Aldosterone-Receptor Antagonists in Uncontrolled Hypertension: A Retrospective Analysis

AT(1)-receptor blockers: differences that matter

A Randomized, Placebo-Controlled, Double-Blind, Parallel Study of Various Doses of Losartan Potassium Compared With Enalapril Maleate in Patients With Essential Hypertension

E079 Comparison of the impact of missed doses of tasosartan and losartan on control of ambulatory blood pressure in essential hypertension

Long-term benefits of angiotensin II blockade: is the consensus changing?

Effects of low-dose oral enoximone administration on mortality, morbidity, and exercise capacity in patients with advanced heart failure: the randomized, double-blind, placebo-controlled, parallel group ESSENTIAL trials

From Left Ventricular Hypertrophy to Congestive Heart Failure: Management of Hypertensive Heart Disease

Combined Enalapril and Felodipine Extended Release (ER) for Systemic Hypertension

Aliskiren, a novel orally effective renin inhibitor, provides dose-dependent antihypertensive efficacy and placebo-like tolerability in hypertensive patients

Supraventricular tachycardia in patients with right hemisphere strokes

Underutilization and clinical benefits of angiotensin-converting enzyme inhibitors in patients with asymptomatic left ventricular dysfunction

Aliskiren, a novel orally effective renin inhibitor, provides antihypertensive efficacy and placebo-like tolerability similar to an at1-receptor blocker in hypertensive patients

Manual or semi-automated edge detection of the maximal far wall common carotid intima-media thickness: a direct comparison

Suchergebnisse filtern